Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 10216075

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
1999 May 1
First author
Relling MV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Relling MV
      type
      Author
    2. name
      Hancock ML
      type
      Author
    3. name
      Boyett JM
      type
      Author
    4. name
      Pui CH
      type
      Author
    5. name
      Evans WE
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Relling MV
      type
      Author
    2. name
      Hancock ML
      type
      Author
    3. name
      Boyett JM
      type
      Author
    4. name
      Pui CH
      type
      Author
    5. name
      Evans WE
      type
      Author
    bibliography ids
    1. nci-bib-6755e21ccc5aa77faaaad3ca
    book metadata
    content sha256
    bfc10c0ea7bf548fb8e701b7280ea5fadc023e54b653814e125424377dfe78b6
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:10216075
      immutable id
      pubmed:10216075@bfc10c0ea7bf548fb8e701b7280ea5fadc023e54b653814e125424377dfe78b6
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      9
      name
      Blood
      nlm unique id
      7603509
      pages
      2817-23
      volume
      93
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        10216075
        provenance
        batch id
        322200bb755447812cbb
        provider
        NCBI PubMed ESummary
        record sha256
        532ca05541a8f5946bc5e7fa8137dea0802feed51ab7c253cf0219bb416539e3
        response sha256
        943a99f9971dfe66ed403e5c181642ea57c7276fe995e9a6a8c892602df084fa
        retrieved at
        2026-09-09T23:45:33.802271+00:00
        publication date
        display
        1999 May 1
        precision
        day
        year
        1999
        publication types
        1. Clinical Trial
        2. Journal Article
        3. Research Support, Non-U.S. Gov't
        4. Research Support, U.S. Gov't, P.H.S.
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/10216075/
        title
        Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.

        Preserved source evidence · Independent clinical review pending · Not medical advice